On Tuesday, May 12, 2015, instrumentation in the core clinical laboratory will be undergoing required maintenance from approximately 09:30 – 13:30. This will delay the resulting of the following assays in that time window:

• Amikacin drug level [LAB555]
• Beta-2 microglobulin [LAB49]
• Carbamazepine drug level [LAB22]
• Ceruloplasmin  [LAB582]
• Drug of abuse – urine screen + confirmation [LAB500 and LAB1032]
• Ethylene glycol, plasma (by immunoassay) [LAB7453]
• Haptoglobin [LAB89]
• Homocysteine [LAB93]
• IgA [LAB73]
• IgG [LAB71]
• IgM [LAB72]
• Keppra (Levetiracetam) drug level [LAB477]
• Lamotrigine (Lamictal) drug level [LAB475]
• Lidocaine drug level [LAB641]
• Lithium drug level [LAB29]
• Methotrexate drug level [LAB481]
• Nicotine metabolite, rapid screen [LAB8071]
• Pentobarbital drug level [LAB656]
• Phenobarbital drug level [LAB30]
• Phenytoin drug level [LAB31]
• Phenytoin free drug level [LAB32]
• Rheumatoid factor [LAB206]
• Theophylline drug level [LAB35]
• Tobramycin drug level [LAB36]
• Valproic acid drug level [LAB25]

Questions should be directed to Matthew Krasowski, MD, PhD, medical director of the Clinical Chemistry Laboratory (384-9380, matthew-krasowski@uiowa.edu).